Exploring an alternative pre-operative sentinel lymph node mapping method using a Magnetic tracer and MRI for potential use in melanoma patients: Imaging subprotocol in healthy participants
Completed
- Conditions
- Melanomaskin cancer10040900
- Registration Number
- NL-OMON49990
- Lead Sponsor
- Heelkunde
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 6
Inclusion Criteria
Healthy participants;
Participants should be *18 years of age at the time of consent;
Participants should be willing to provide informed consent.
Exclusion Criteria
Known intolerance/hypersensitivity to iron, dextran compounds or Magtrace®
itself;
Standard MRI exclusion criteria:
- Implantable (electrical) devices (e.g. pacemaker, cochlear implants,
neurostimulator);
- Any other metal implants
- Claustrophobia;
- MR-incompatible prosthetic heart valves;
- Tattoos inked with metallic dye.
Participants who refuse to provide informed consent.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method